Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,786

Class I recallsReasonable probability of serious health consequences

24,313

Class II recallsTemporary or medically reversible health consequences

2,876

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026

Most affected stateHawaii 200 recalls mention this state

State: VI ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 14, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

FDA Recall Completed Historical recordClass II

QM-4 Papaverine 30 mg/mL Phentolamine 3 mg/mL Alprostadil 300 mcg/mL Atropine 0.2 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0020-10

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason: Lack of assurance of sterility.
Published: June 1, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 49702-228-13.

by GlaxoSmithKline LLC

Reason: Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.
Published: June 1, 2022
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3

by Noven Pharmaceuticals Inc

Reason: Defective Delivery System: customer complaints exceeded respective action limits.
Published: June 1, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Zonisamide Capsules USP, 100 mg, 90-count bottle, Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90

by Direct Rx

Reason: CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Published: June 1, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2

by Apotex Corp.

Reason: Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.
Published: May 25, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blisters per card, 10 cards per carton, Unit Dose NDC 68084-446-11, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 68084-446-01

by American Health Packaging

Reason: Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.
Published: May 25, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19

by Lupin Pharmaceuticals Inc.

Reason: Failed Stability Specification
Published: May 25, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

by Pfizer Inc.

Reason: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Published: May 25, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

by Pfizer Inc.

Reason: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Published: May 25, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

by Pfizer Inc.

Reason: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Published: May 25, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Nandrolone Decanoate, USP, 1 kg per plastic container, Rx Only, For Prescription Compounding, Distributed by: Humco, 7400 Alumax Road, Texarkana, TX 75501. NDC 0395-8212-43

by Fagron, Inc

Reason: Subpotent Drug
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescription Compounding, Distributed by: Humco, 7400 Alumax Road, Texarkana, TX 75501. NDC 0395-8212-56

by Fagron, Inc

Reason: Subpotent Drug
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Nandrolone Decanoate, USP, 1 kg per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot Knob Rd., St Paul, MN 55120. NDC 51552-1564-07

by Fagron, Inc

Reason: Subpotent Drug
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot Knob Rd., St Paul, MN 55120. NDC 51552-1564-05

by Fagron, Inc

Reason: Subpotent Drug
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Nandrolone Decanoate, USP, 100 g per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot Knob Rd., St Paul, MN 55120. NDC 51552-1564-04

by Fagron, Inc

Reason: Subpotent Drug
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-010-16

by Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Reason: Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-009-16

by Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Reason: Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-738-86

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason: Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 150 mg packaged in a) 60-count bottle (47335-737-86), b)100-count bottle (47335-737-88), c)500-count bottle (47335-737-13), Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason: Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.
Published: May 18, 2022
Distribution: Nationwide

View recall →

FDA Recall Completed Historical recordClass I

SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-1123-5) and b) 4L bottles (NDC 51552-1123-9), Rx Only, Manufactured for Fagron, Inc., St. Paul, MN 55120.

by Fagron, Inc

Reason: Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.
Published: May 18, 2022
Distribution: Nationwide

View recall →

Data last updated: September 14, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.